Transaction · 0001231919-26-001158
ALMSALUMIS INC.
Akkaraju Srinivas
AKKARAJU SRINIVAS, DIR, reported an open-market or private purchase at ALUMIS INC. involving 220070.000000 shares for an estimated $2458842.11. Reported holdings after the transaction were 4711801.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Open-market buySEC transaction code PDIR
- Trade date
- Sep 04, 2026
- Filing date
- Sep 10, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 4,491,731 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingdelayed filingThe filing was reported 6 calendar days after the transaction date.
ALMS price since this filing
Daily closing prices, with the filing date and available return windowsALMS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +173.9%1w ago +126.1%1d ago +14.7%
Returns since7d -21.0%30d -27.7%90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001231919-26-001158 Common Stock
- Transaction date
- Sep 04, 2026 Filed Sep 10, 2026, 01:39 AM · 6d delay
- Shares
- 220,070 sh $11.17 per share
- Estimated value
- $2.45M Computed from shares × price
- Holdings after
- 4,711,801 sh Indirect · By Samsara BioCapital, L.P.
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Delayed Filing Director Buy Large Buy
Filing-only score
+22 points
Compact filing score computed from stored Form 4 facts. Version v1.
Positive filing signal
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - director_buy+6 points
is_director = true
Director open-market purchase. - large_buy_absolute+10 points
large-buy signal with absolute_triggered = true
Open-market purchase exceeds the configured absolute threshold. - delayed_filing-6 points
reporting_delay_days = 6
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector Yes10% NoOther No
Footnotes & amended
- F1
The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $11.02 to $11.60, inclusive. The Reporting Person undertake…
- F2F3(2 footnotes)
Shares are directly held by Samsara BioCapital LP. ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disc…
- F4
The sales and purchases on September 8, 2026 were matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 48,066 shares in the case of Samsara LP and 48,065 shares in th…
- F5
The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $10.38 to $10.91, inclusive. The Reporting Person undertake to pr…
- F6
The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $10.26 to $10.835, inclusive. The Reporting Person undertake…
Related transactions
Same SEC filing0 other transactions
Recent company activity
ALMS0 recent txs